5-[[5-Amino-1-[[10-(3-amino-3-oxopropyl)-4-butan-2-yl-22-(2-carboxyethyl)-25-(1-hydroxyethyl)-7-[(4-hydroxyphenyl)methyl]-19-methyl-3,6,9,12,18,21,24,27-octaoxo-2-oxa-5,8,11,17,20,23,26-heptazatricyclo[28.2.2.013,17]tetratriaconta-1(33),30(34),31-trien-28-yl]amino]-1-oxopentan-2-yl]amino]-4-[(3-hydroxy-14-methylpentadecanoyl)amino]-5-oxopentanoic acid
| Internal ID | 8fb56a6c-61f7-4a6b-86bb-d680d1bc4bd3 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | 5-[[5-amino-1-[[10-(3-amino-3-oxopropyl)-4-butan-2-yl-22-(2-carboxyethyl)-25-(1-hydroxyethyl)-7-[(4-hydroxyphenyl)methyl]-19-methyl-3,6,9,12,18,21,24,27-octaoxo-2-oxa-5,8,11,17,20,23,26-heptazatricyclo[28.2.2.013,17]tetratriaconta-1(33),30(34),31-trien-28-yl]amino]-1-oxopentan-2-yl]amino]-4-[(3-hydroxy-14-methylpentadecanoyl)amino]-5-oxopentanoic acid |
| SMILES (Canonical) | CCC(C)C1C(=O)OC2=CC=C(CC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)N1)CC4=CC=C(C=C4)O)CCC(=O)N)C)CCC(=O)O)C(C)O)NC(=O)C(CCCN)NC(=O)C(CCC(=O)O)NC(=O)CC(CCCCCCCCCCC(C)C)O)C=C2 |
| SMILES (Isomeric) | CCC(C)C1C(=O)OC2=CC=C(CC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)N1)CC4=CC=C(C=C4)O)CCC(=O)N)C)CCC(=O)O)C(C)O)NC(=O)C(CCCN)NC(=O)C(CCC(=O)O)NC(=O)CC(CCCCCCCCCCC(C)C)O)C=C2 |
| InChI | InChI=1S/C72H110N12O20/c1-7-42(4)61-72(103)104-49-28-24-46(25-29-49)39-55(80-64(95)50(20-16-36-73)77-65(96)51(31-34-59(90)91)76-58(89)40-48(87)19-15-13-11-9-8-10-12-14-18-41(2)3)68(99)83-62(44(6)85)70(101)79-53(32-35-60(92)93)63(94)75-43(5)71(102)84-37-17-21-56(84)69(100)78-52(30-33-57(74)88)66(97)81-54(67(98)82-61)38-45-22-26-47(86)27-23-45/h22-29,41-44,48,50-56,61-62,85-87H,7-21,30-40,73H2,1-6H3,(H2,74,88)(H,75,94)(H,76,89)(H,77,96)(H,78,100)(H,79,101)(H,80,95)(H,81,97)(H,82,98)(H,83,99)(H,90,91)(H,92,93) |
| InChI Key | FTJPYILLHHIIOP-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C72H110N12O20 |
| Molecular Weight | 1463.70 g/mol |
| Exact Mass | 1462.79593394 g/mol |
| Topological Polar Surface Area (TPSA) | 513.00 Ų |
| XlogP | 2.20 |
| Atomic LogP (AlogP) | 0.94 |
| H-Bond Acceptor | 19 |
| H-Bond Donor | 16 |
| Rotatable Bonds | 35 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6101 | 61.01% |
| Caco-2 | - | 0.8635 | 86.35% |
| Blood Brain Barrier | - | 0.9750 | 97.50% |
| Human oral bioavailability | - | 0.6857 | 68.57% |
| Subcellular localzation | Lysosomes | 0.5479 | 54.79% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8289 | 82.89% |
| OATP1B3 inhibitior | + | 0.9264 | 92.64% |
| MATE1 inhibitior | - | 0.8400 | 84.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9583 | 95.83% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8893 | 88.93% |
| CYP3A4 substrate | + | 0.7487 | 74.87% |
| CYP2C9 substrate | - | 0.5968 | 59.68% |
| CYP2D6 substrate | - | 0.7892 | 78.92% |
| CYP3A4 inhibition | - | 0.7161 | 71.61% |
| CYP2C9 inhibition | - | 0.9069 | 90.69% |
| CYP2C19 inhibition | - | 0.8657 | 86.57% |
| CYP2D6 inhibition | - | 0.8535 | 85.35% |
| CYP1A2 inhibition | - | 0.9594 | 95.94% |
| CYP2C8 inhibition | + | 0.8179 | 81.79% |
| CYP inhibitory promiscuity | - | 0.9317 | 93.17% |
| UGT catelyzed | - | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.5960 | 59.60% |
| Eye corrosion | - | 0.9892 | 98.92% |
| Eye irritation | - | 0.8957 | 89.57% |
| Skin irritation | - | 0.7890 | 78.90% |
| Skin corrosion | - | 0.9292 | 92.92% |
| Ames mutagenesis | - | 0.6837 | 68.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7227 | 72.27% |
| Micronuclear | + | 0.8700 | 87.00% |
| Hepatotoxicity | - | 0.5323 | 53.23% |
| skin sensitisation | - | 0.8829 | 88.29% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.9333 | 93.33% |
| Mitochondrial toxicity | + | 0.9375 | 93.75% |
| Nephrotoxicity | + | 0.4875 | 48.75% |
| Acute Oral Toxicity (c) | III | 0.5632 | 56.32% |
| Estrogen receptor binding | + | 0.6149 | 61.49% |
| Androgen receptor binding | + | 0.7414 | 74.14% |
| Thyroid receptor binding | + | 0.6633 | 66.33% |
| Glucocorticoid receptor binding | + | 0.7677 | 76.77% |
| Aromatase binding | + | 0.7482 | 74.82% |
| PPAR gamma | + | 0.7501 | 75.01% |
| Honey bee toxicity | - | 0.6655 | 66.55% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | + | 0.5500 | 55.00% |
| Fish aquatic toxicity | + | 0.9596 | 95.96% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.97% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.32% | 96.09% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.82% | 91.11% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.81% | 94.45% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.63% | 96.61% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 98.03% | 82.38% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 97.89% | 99.17% |
| CHEMBL236 | P41143 | Delta opioid receptor | 97.67% | 99.35% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 97.29% | 90.71% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 96.44% | 90.08% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.34% | 97.09% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 96.27% | 85.14% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 95.94% | 93.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.56% | 94.66% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 94.68% | 94.45% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 94.43% | 95.89% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 93.59% | 98.05% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 93.21% | 90.20% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.01% | 93.56% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 92.39% | 100.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.95% | 96.47% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 91.76% | 88.10% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 91.52% | 95.50% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 91.13% | 97.23% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 90.96% | 96.11% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 90.91% | 95.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 90.79% | 96.67% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 90.66% | 96.90% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 90.52% | 95.56% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 90.36% | 97.64% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 90.33% | 98.94% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 90.15% | 97.14% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 89.80% | 94.75% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 89.59% | 95.89% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 89.41% | 89.50% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 87.65% | 85.00% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 87.30% | 90.93% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 87.25% | 97.05% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 87.16% | 88.42% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 86.81% | 100.00% |
| CHEMBL4633 | P22001 | Voltage-gated potassium channel subunit Kv1.3 | 85.60% | 100.00% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 85.55% | 96.33% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 83.78% | 98.33% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 82.98% | 99.18% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 82.57% | 98.00% |
| CHEMBL2243 | O00519 | Anandamide amidohydrolase | 82.44% | 97.53% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 81.70% | 93.10% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 81.48% | 97.33% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 81.14% | 91.19% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 81.04% | 95.92% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 80.82% | 82.69% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 80.39% | 100.00% |
| CHEMBL241 | Q14432 | Phosphodiesterase 3A | 80.28% | 92.94% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 60076016 |
| LOTUS | LTS0005589 |
| wikiData | Q105105558 |